Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis. - Wikidata - wikimedia - TriplyDB

Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis.

Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis.

http://www.wikidata.org/entity/Q37717181

about

Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis.

http://www.wikidata.org/entity/Q37717181

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Perioperative Epirubicin, Oxal ...... an Interim Survival Analysis.

@en

Perioperative Epirubicin, Oxal ...... an Interim Survival Analysis.

@nl

type

label

Perioperative Epirubicin, Oxal ...... an Interim Survival Analysis.

@en

Perioperative Epirubicin, Oxal ...... an Interim Survival Analysis.

@nl

prefLabel

Perioperative Epirubicin, Oxal ...... an Interim Survival Analysis.

@en

Perioperative Epirubicin, Oxal ...... an Interim Survival Analysis.

@nl

P1433

Q37717181-40233AB4-3793-4632-904B-43A740E63E46

P1476

Q37717181-0FAB6D67-8B3F-4969-B941-28333CDDCB70

P2093

Q37717181-0A4C969C-57B4-4884-8969-6B28631F21FE

Q37717181-0F0C09ED-C552-45BC-81CD-0AAA0FCE4230

Q37717181-189CE9FC-F089-441E-8139-82067B639830

Q37717181-1A0298F5-6BE6-44BC-92CE-4C0A9A3C4E2A

Q37717181-293F7221-2E04-4B2A-AE4F-9E00DB6585C7

Q37717181-2C101DBA-B56B-480D-BE31-0D04EEA451F7

Q37717181-88217260-51EE-4AC6-8896-87B0ACCE98CF

Q37717181-B6582EF1-96A7-4216-91CC-45B4F92D0A38

Q37717181-E4EC8E0C-CFD4-4F1F-8809-2DBE817EE9DF

P2860

Q37717181-0C34EDD9-7476-4291-9A1D-30286CF791A8

Q37717181-0CE55065-407E-4BE9-9467-B43DD8AD09C2

Q37717181-0DCFAA82-97A9-4A8E-B3EA-94885719F5B3

Q37717181-1A2D1467-4D70-4455-9800-12AFBAFD6C87

Q37717181-1B7AB517-5942-4C51-AB56-A5F689B7C588

Q37717181-25622EF2-D07B-4B15-927D-F560ECB00370

Q37717181-707D1E45-802A-4F4D-B4B7-EA09EFA872BC

Q37717181-7D611A7F-A70E-4433-8629-A1A010ED2697

Q37717181-8D45AE10-3120-40DC-BE22-11AB0CDC9D81

Q37717181-8E7F55FB-5726-4167-8782-C67C6934D7D3

P304

Q37717181-5234FF0F-15AC-4407-BF63-1839F88D85CF

P31

Q37717181-B00CA8BD-EF4E-411F-BF2B-F6DBDF117F23

P356

Q37717181-39D29F45-2C5E-4D87-9217-27B65BD64050

P433

Q37717181-E00D6113-0B7A-4D5B-9AC5-095CCE794470

P478

Q37717181-FD687D2A-4970-4FF7-8851-971532F4BE9C

P50

Q37717181-28A68715-FA67-481C-8A32-7B4C9D3149CF

P577

Q37717181-6A4C1F00-1F99-410F-AC0E-24B08055B65D

P698

Q37717181-FF70D7AB-7F1B-432C-9165-9CBA8EA1A83B

P921

Q37717181-E3EDACF5-6D67-408F-9EDA-BA782207763C

P932

Q37717181-A4B35827-F393-446C-9A15-8995C036D717

P356

P1433

Journal of gastric cancer

P1476

Perioperative Epirubicin, Oxal ...... an Interim Survival Analysis.

@en

P2093

Anant Ramaswamy

http://www.w3.org/2001/XMLSchema#string

Arvind Sahu

http://www.w3.org/2001/XMLSchema#string

Ashwin Desouza

http://www.w3.org/2001/XMLSchema#string

Bhawna Sirohi

http://www.w3.org/2001/XMLSchema#string

Mahesh Goel

http://www.w3.org/2001/XMLSchema#string

Shailesh V Shrikhande

http://www.w3.org/2001/XMLSchema#string

Shraddha Patkar

http://www.w3.org/2001/XMLSchema#string

Subhadeep Bose

http://www.w3.org/2001/XMLSchema#string

Vikas Talreja

http://www.w3.org/2001/XMLSchema#string

P2860

Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus

Cancer statistics, 2010

Cancer statistics, 2016

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials.

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

P304

21-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5230/JGC.2017.17.E3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28337360

http://www.w3.org/2001/XMLSchema#string

P921

P932

5362831

http://www.w3.org/2001/XMLSchema#string